Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,556.37
(
-0.37%
)
US TECH 100
23,547.20
(
0.12%
)
Dow Jones
46,124.06
(
-0.18%
)
Brent Oil
96.62
(
0.12%
)
Bitcoin
70,726.99
(
0.30%
)
News Focus
News Focus
Post# of 257275
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

AlpineBV_Miller

Send PM Follow Ignore
Followers 54
Posts 1150
Boards Moderated 0
Alias Born 11/12/2005

AlpineBV_Miller

Re: DewDiligence post# 115420

Thursday, 02/24/2011 2:16:09 AM

Thursday, February 24, 2011 2:16:09 AM

Post# of 257275

While you might be able to fool the FDA, you probably wouldn’t fool ODAC



If Pazdur writes the SPA based upon a MSKCC-designed protocol, and this trial WILL have a SPA using a protocol designed by MSKCC, ODAC will follow along. There are few things in life that are certain where Pazdur and ODAC are involved, but that would be one of them.

Unless otherwise indicated, this is the personal viewpoint of David
Miller and not necessarily that of Biotech Stock Research, LLC.
We're on Twitter at BiotechStockRsr

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today